Logo image of STAR7.MI

STAR7 S.P.A. (STAR7.MI) Stock Fundamental Analysis

Europe - BIT:STAR7 - IT0005466195 - Common Stock

5.9 EUR
-0.15 (-2.48%)
Last: 9/1/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to STAR7. STAR7 was compared to 41 industry peers in the Commercial Services & Supplies industry. While STAR7 has a great profitability rating, there are some minor concerns on its financial health. STAR7 scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make STAR7 a good candidate for value investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year STAR7 was profitable.
STAR7 had a positive operating cash flow in the past year.
In the past 5 years STAR7 has always been profitable.
STAR7 had a positive operating cash flow in each of the past 5 years.
STAR7.MI Yearly Net Income VS EBIT VS OCF VS FCFSTAR7.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

STAR7's Return On Assets of 2.32% is fine compared to the rest of the industry. STAR7 outperforms 63.41% of its industry peers.
With a decent Return On Equity value of 8.82%, STAR7 is doing good in the industry, outperforming 60.98% of the companies in the same industry.
STAR7 has a Return On Invested Capital of 7.39%. This is amongst the best in the industry. STAR7 outperforms 80.49% of its industry peers.
STAR7 had an Average Return On Invested Capital over the past 3 years of 6.44%. This is in line with the industry average of 7.19%.
The 3 year average ROIC (6.44%) for STAR7 is below the current ROIC(7.39%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.32%
ROE 8.82%
ROIC 7.39%
ROA(3y)2.32%
ROA(5y)2.43%
ROE(3y)8.63%
ROE(5y)9.85%
ROIC(3y)6.44%
ROIC(5y)5.62%
STAR7.MI Yearly ROA, ROE, ROICSTAR7.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With a decent Profit Margin value of 2.24%, STAR7 is doing good in the industry, outperforming 60.98% of the companies in the same industry.
In the last couple of years the Profit Margin of STAR7 has declined.
The Operating Margin of STAR7 (7.79%) is better than 68.29% of its industry peers.
In the last couple of years the Operating Margin of STAR7 has remained more or less at the same level.
With a decent Gross Margin value of 58.90%, STAR7 is doing good in the industry, outperforming 68.29% of the companies in the same industry.
In the last couple of years the Gross Margin of STAR7 has grown nicely.
Industry RankSector Rank
OM 7.79%
PM (TTM) 2.24%
GM 58.9%
OM growth 3Y4.82%
OM growth 5Y-1.09%
PM growth 3Y-15.36%
PM growth 5Y-13.37%
GM growth 3Y2.02%
GM growth 5Y4.28%
STAR7.MI Yearly Profit, Operating, Gross MarginsSTAR7.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), STAR7 is creating some value.
Compared to 1 year ago, STAR7 has about the same amount of shares outstanding.
STAR7 has about the same amout of shares outstanding than it did 5 years ago.
STAR7 has a worse debt/assets ratio than last year.
STAR7.MI Yearly Shares OutstandingSTAR7.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
STAR7.MI Yearly Total Debt VS Total AssetsSTAR7.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

STAR7 has an Altman-Z score of 2.26. This is not the best score and indicates that STAR7 is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.26, STAR7 is in the better half of the industry, outperforming 73.17% of the companies in the same industry.
STAR7 has a debt to FCF ratio of 5.28. This is a neutral value as STAR7 would need 5.28 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.28, STAR7 is in the better half of the industry, outperforming 68.29% of the companies in the same industry.
A Debt/Equity ratio of 1.27 is on the high side and indicates that STAR7 has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.27, STAR7 is doing worse than 63.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 5.28
Altman-Z 2.26
ROIC/WACC1.29
WACC5.73%
STAR7.MI Yearly LT Debt VS Equity VS FCFSTAR7.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.99 indicates that STAR7 should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.99, STAR7 belongs to the top of the industry, outperforming 80.49% of the companies in the same industry.
STAR7 has a Quick Ratio of 1.93. This is a normal value and indicates that STAR7 is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of STAR7 (1.93) is better than 85.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.93
STAR7.MI Yearly Current Assets VS Current LiabilitesSTAR7.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

STAR7 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.36%, which is quite impressive.
STAR7 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.72% yearly.
STAR7 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.77%.
The Revenue has been growing by 18.57% on average over the past years. This is quite good.
EPS 1Y (TTM)48.36%
EPS 3Y7.19%
EPS 5Y2.72%
EPS Q2Q%68.97%
Revenue 1Y (TTM)14.77%
Revenue growth 3Y26.64%
Revenue growth 5Y18.57%
Sales Q2Q%11.04%

3.2 Future

The Earnings Per Share is expected to grow by 14.44% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.27% on average over the next years.
EPS Next Y22.77%
EPS Next 2Y24.85%
EPS Next 3Y14.44%
EPS Next 5YN/A
Revenue Next Year4.55%
Revenue Next 2Y5.14%
Revenue Next 3Y5.27%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
STAR7.MI Yearly Revenue VS EstimatesSTAR7.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M
STAR7.MI Yearly EPS VS EstimatesSTAR7.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

7

4. Valuation

4.1 Price/Earnings Ratio

STAR7 is valuated rather expensively with a Price/Earnings ratio of 19.67.
Based on the Price/Earnings ratio, STAR7 is valued a bit cheaper than 63.41% of the companies in the same industry.
STAR7 is valuated rather cheaply when we compare the Price/Earnings ratio to 27.43, which is the current average of the S&P500 Index.
STAR7 is valuated reasonably with a Price/Forward Earnings ratio of 8.24.
Based on the Price/Forward Earnings ratio, STAR7 is valued cheaper than 92.68% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, STAR7 is valued rather cheaply.
Industry RankSector Rank
PE 19.67
Fwd PE 8.24
STAR7.MI Price Earnings VS Forward Price EarningsSTAR7.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, STAR7 is valued cheaper than 87.80% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, STAR7 is valued cheaply inside the industry as 87.80% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.26
EV/EBITDA 4.58
STAR7.MI Per share dataSTAR7.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
STAR7 has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as STAR7's earnings are expected to grow with 14.44% in the coming years.
PEG (NY)0.86
PEG (5Y)7.23
EPS Next 2Y24.85%
EPS Next 3Y14.44%

0

5. Dividend

5.1 Amount

No dividends for STAR7!.
Industry RankSector Rank
Dividend Yield N/A

STAR7 S.P.A.

BIT:STAR7 (9/1/2025, 7:00:00 PM)

5.9

-0.15 (-2.48%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners12.75%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap53.10M
Analysts86
Price Target11.93 (102.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.67
Fwd PE 8.24
P/S 0.44
P/FCF 5.26
P/OCF 3.28
P/B 1.74
P/tB N/A
EV/EBITDA 4.58
EPS(TTM)0.3
EY5.08%
EPS(NY)0.72
Fwd EY12.14%
FCF(TTM)1.12
FCFY19.01%
OCF(TTM)1.8
OCFY30.53%
SpS13.31
BVpS3.39
TBVpS-0.37
PEG (NY)0.86
PEG (5Y)7.23
Profitability
Industry RankSector Rank
ROA 2.32%
ROE 8.82%
ROCE 11.61%
ROIC 7.39%
ROICexc 10.81%
ROICexgc 28.11%
OM 7.79%
PM (TTM) 2.24%
GM 58.9%
FCFM 8.42%
ROA(3y)2.32%
ROA(5y)2.43%
ROE(3y)8.63%
ROE(5y)9.85%
ROIC(3y)6.44%
ROIC(5y)5.62%
ROICexc(3y)8.52%
ROICexc(5y)7.45%
ROICexgc(3y)23.28%
ROICexgc(5y)20.62%
ROCE(3y)10.12%
ROCE(5y)8.83%
ROICexcg growth 3Y7.36%
ROICexcg growth 5Y-3.75%
ROICexc growth 3Y30.56%
ROICexc growth 5Y-11.19%
OM growth 3Y4.82%
OM growth 5Y-1.09%
PM growth 3Y-15.36%
PM growth 5Y-13.37%
GM growth 3Y2.02%
GM growth 5Y4.28%
F-Score7
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 5.28
Debt/EBITDA 2.2
Cap/Depr 73.51%
Cap/Sales 5.1%
Interest Coverage 250
Cash Conversion 91.81%
Profit Quality 375.38%
Current Ratio 1.99
Quick Ratio 1.93
Altman-Z 2.26
F-Score7
WACC5.73%
ROIC/WACC1.29
Cap/Depr(3y)82.32%
Cap/Depr(5y)146.9%
Cap/Sales(3y)6.49%
Cap/Sales(5y)8.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.36%
EPS 3Y7.19%
EPS 5Y2.72%
EPS Q2Q%68.97%
EPS Next Y22.77%
EPS Next 2Y24.85%
EPS Next 3Y14.44%
EPS Next 5YN/A
Revenue 1Y (TTM)14.77%
Revenue growth 3Y26.64%
Revenue growth 5Y18.57%
Sales Q2Q%11.04%
Revenue Next Year4.55%
Revenue Next 2Y5.14%
Revenue Next 3Y5.27%
Revenue Next 5YN/A
EBIT growth 1Y46.61%
EBIT growth 3Y32.75%
EBIT growth 5Y17.28%
EBIT Next Year83.25%
EBIT Next 3Y30.08%
EBIT Next 5YN/A
FCF growth 1Y410.67%
FCF growth 3Y38.29%
FCF growth 5YN/A
OCF growth 1Y150.99%
OCF growth 3Y17.98%
OCF growth 5YN/A